- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03978650
Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders
Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders in the Older Canadian Population: A Population-based, Prospective, Longitudinal, Observational Cohort Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Falls are frequent events in adults over age 65 (up to 30% each year in Canada). They are a major Canadian public health concern, which negatively impacts health and quality of life of fallers, and health care system. Neurocognitive disorders are strongly associated with falls and fall-related injuries.
Several clinical characteristics, identified previously as risk factors for falls in the older population and in older adults with neurocognitive disorders are selected in the Canadian Longitudinal Study On Aging. The performance criteria of different statistical models will be compared for the association of neurocognitive disorders with falls and fall-related injuries. Six linear statistical models (i.e., logistic regression, discriminant analysis, Bayes network algorithm, decision tree, random forest, boosted trees), Factor Mixture Models and two different artificial neural network (i.e., multilayer perceptron and the neuroevolution of augmenting topologies).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H3T 1E2
- Jewish General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
- People from Canada who are 65 years and over.
- Men and women who were enrolled into the Canadian Longitudinal Study on Aging
- Participants who attended the face-to-face interview questionnaires about diet, medication use, chronic disease symptoms, and sleep disorders.
Description
Inclusion Criteria:
- People who are 65 years and over
- Men and women who live in Canada
Exclusion Criteria:
- People who do not live in Canada
- A fall resulting from acute medical event and/or an external factor
- Moderate to severe dementia
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fall Injury
Time Frame: 18 months
|
Incident falls occurring during the 18 months.
Information related fall- injuries will also be collected, including fractures, dislocations, voluminous intracranial or peripheral hematomas, trauma of the face, and cutaneous lacerations of significant size and/or deeper than the hypodermis, possibly resulting in medical consultation or hospitalization.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Auditory verbal memory disorder
Time Frame: around 20 years
|
Investigator will use the Rey Auditory Verbal Test that evaluates the auditory-verbal memory.
|
around 20 years
|
|
The Mental Alteration Test
Time Frame: around 20 years
|
Investigator will evaluate the amnesia
|
around 20 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Olivier Beauchet, MD, Jewish General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-1804
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurocognitive Disorders
-
Chinese Academy of Medical Sciences, Fuwai HospitalNot yet recruitingCardiac Surgery | Neurocognitive DisorderChina
-
Jinan Central HospitalRecruitingPerioperative Neurocognitive DysfunctionChina
-
Qianfoshan HospitalNot yet recruitingFrail Elderly | Perioperative Neurocognitive Disorders
-
Universidad de MurciaCompletedNeurocognitive Disorder, Etiology of Neurocognitive DisorderSpain
-
Xijing HospitalNot yet recruitingPerioperative Neurocognitive Disorders
-
UMC UtrechtGilead SciencesCompletedHIV Associated Neurocognitive Disorder | Neurocognitive DeclineNetherlands
-
Shanghai 10th People's HospitalNational Natural Science Foundation of ChinaRecruitingPerioperative Neurocognitive DisorderChina
-
Posit Science CorporationCompletedHIV-associated Neurocognitive DysfunctionUnited States
-
Beijing Chao Yang HospitalRecruitingCardiovascular Surgery | Perioperative Neurocognitive DisordersChina
-
Charite University, Berlin, GermanyCompletedNeurocognitive DysfunctionGermany
Clinical Trials on Observational
-
Massachusetts General HospitalRecruiting
-
Taysha Gene Therapies, Inc.Withdrawn
-
University Hospital, AntwerpUniversiteit AntwerpenUnknownType 1 Diabetes | Diastolic Dysfunction | Coronary Artery CalcificationsBelgium
-
St. Louis UniversityRecruitingVertebral Artery StenosisUnited States
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
Drexel UniversityCompletedOsteoporosisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Center for Advancing Translational...CompletedHead and Neck Cancer | Chronic Obstructive Pulmonary Disease | Lung CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Leukemia | Chemotherapy-Induced Gut Barrier DamageUnited States